In this issue:
Higher FC threshold needed to diagnose paediatric IBD
New therapies decrease colectomy rates in paediatric UC
Upadacitinib is effective and safe to treat UC and CD
Long-term risk of stroke in patients with IBD
Increased risk of cervical neoplasia with cumulative exposure to IM
Early remission with induction therapy predicts sustained remission in IBD
Patients with high visceral adipose tissue burden may need more infliximab
MSE bests SBE in deeper bowel evaluation for CD
Updated ECCO guideline on IBD and malignancies
Pharmacological management of chronic idiopathic constipation
Enteric nervous system relays psychological stress to intestinal inflammation
Financial burden, distress, and toxicity of IBD in the US
COVID-19 resources
Conferences, workshops, and CPD
Please login below to download this issue (PDF)